{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:13:06Z","timestamp":1788545586250,"version":"build-2803163510"},"reference-count":42,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Intracranial hypertension is a major modifiable pathway of secondary brain injury after acute neurological insults. Osmotherapy is an early cornerstone of tiered intracranial pressure management. Hypertonic saline and mannitol reliably reduce intracranial pressure through osmotic reduction in brain water, with additional haemodynamic and rheological effects. However, neither agent has shown consistent improvement in survival or long-term neurological recovery. Current practice is therefore guided by physiological rather than patient-centred outcomes. This review summarises the physiological basis, clinical evidence, and practical limitations of conventional osmotherapy, and explores investigational chloride-free osmotherapies including sodium lactate, sodium bicarbonate, sodium ascorbate, and sodium acetate. Chloride-free therapies aim to preserve sodium-driven osmotic efficacy while reducing chloride exposure or targeting metabolic and oxidative pathways implicated in secondary brain injury. At present, evidence is limited to small physiological trials, retrospective cohort studies, and mechanistic human studies. Future progress requires large collaborative trials that combine pragmatic treatment comparisons with multimodal neuromonitoring, biochemical safety endpoints and patient-centred outcomes.<\/jats:p>","DOI":"10.3390\/jcm15176860","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:25:56Z","timestamp":1788542756000},"page":"6860","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An Update on Osmotherapy in Acute Brain Injury: Current and Emerging Strategies"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8040-0164","authenticated-orcid":false,"given":"Sarah A.","family":"Howson","sequence":"first","affiliation":[{"name":"Central Adelaide Local Health Network, Adelaide, SA 5000, Australia"},{"name":"College of Health, Adelaide University, Adelaide, SA 5000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3903-6293","authenticated-orcid":false,"given":"Benjamin","family":"Reddi","sequence":"additional","affiliation":[{"name":"Central Adelaide Local Health Network, Adelaide, SA 5000, Australia"},{"name":"College of Health, Adelaide University, Adelaide, SA 5000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7485-4883","authenticated-orcid":false,"given":"Rebecca J.","family":"Hood","sequence":"additional","affiliation":[{"name":"College of Health, Adelaide University, Adelaide, SA 5000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9e J.","family":"Turner","sequence":"additional","affiliation":[{"name":"College of Health, Adelaide University, Adelaide, SA 5000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9640-1911","authenticated-orcid":false,"given":"Mark P.","family":"Plummer","sequence":"additional","affiliation":[{"name":"Central Adelaide Local Health Network, Adelaide, SA 5000, Australia"},{"name":"College of Health, Adelaide University, Adelaide, SA 5000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.5005\/jp-journals-10071-23190","article-title":"Raised Intracranial Pressure Syndrome: A Stepwise Approach","volume":"23","author":"Tripathy","year":"2019","journal-title":"Indian J. Crit. Care Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1227\/NEU.0000000000001432","article-title":"Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition","volume":"80","author":"Carney","year":"2017","journal-title":"Neurosurgery"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s00134-019-05805-9","article-title":"A management algorithm for patients with intracranial pressure monitoring: The Seattle International Severe Traumatic Brain Injury Consensus Conference (SIBICC)","volume":"45","author":"Hawryluk","year":"2019","journal-title":"Intensive Care Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"686","DOI":"10.5005\/jp-journals-10071-24746","article-title":"Efficacy of Intravenous 20% Mannitol vs 3% Hypertonic Saline in Reducing Intracranial Pressure in Nontraumatic Brain Injury: A Systematic Review and Meta-analysis","volume":"28","author":"Choudhury","year":"2024","journal-title":"Indian J. Crit. Care Med."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Chen, H., Song, Z., and Dennis, J.A. (2020). Hypertonic saline versus other intracranial pressure-lowering agents for people with acute traumatic brain injury. Cochrane Database Syst. Rev., 1.","DOI":"10.1002\/14651858.CD010904.pub3"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Gharizadeh, N., Ghojazadeh, M., Naseri, A., Dolati, S., Tarighat, F., and Soleimanpour, H. (2022). Hypertonic saline for traumatic brain injury: A systematic review and meta-analysis. Eur. J. Med. Res., 27.","DOI":"10.1186\/s40001-022-00897-4"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1089\/neu.2022.0465","article-title":"Comparative Effectiveness of Mannitol Versus Hypertonic Saline in Patients with Traumatic Brain Injury: A CENTER-TBI Study","volume":"40","author":"Nieboer","year":"2023","journal-title":"J. Neurotrauma"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.wneu.2022.03.056","article-title":"Hypertonic Saline Treatment in Traumatic Brain Injury: A Systematic Review","volume":"162","author":"Mekonnen","year":"2022","journal-title":"World Neurosurg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.bjae.2018.05.005","article-title":"Osmotherapy: Science and evidence-based practice","volume":"18","author":"Freeman","year":"2018","journal-title":"BJA Educ."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Boone, M.D., Oren-Grinberg, A., Robinson, T.M., Chen, C.C., and Kasper, E.M. (2015). Mannitol or hypertonic saline in the setting of traumatic brain injury: What have we learned?. Surg. Neurol. Int., 6.","DOI":"10.4103\/2152-7806.170248"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4274\/MMJ.galenos.2022.75725","article-title":"Optimal Dose and Concentration of Hypertonic Saline in Traumatic Brain Injury: A Systematic Review","volume":"37","author":"Susanto","year":"2022","journal-title":"Medeni. Med. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/SHK.0000000000001169","article-title":"Hypertonic Saline Solution Reduces Microcirculatory Dysfunction and Inflammation in a Rat Model of Brain Death","volume":"51","author":"Correia","year":"2019","journal-title":"Shock"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Pigott, A., and Rudloff, E. (2021). Traumatic Brain Injury-A Review of Intravenous Fluid Therapy. Front. Vet. Sci., 8.","DOI":"10.3389\/fvets.2021.643800"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1080\/02699052.2024.2363340","article-title":"Effectiveness of hypertonic saline infusion in management of traumatic brain injury: An updated systematic review and meta-analysis of randomized controlled trials","volume":"38","author":"Cai","year":"2024","journal-title":"Brain Inj."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s12028-020-00959-7","article-title":"Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients","volume":"32","author":"Cook","year":"2020","journal-title":"Neurocrit. Care"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"McIlroy, P., Ramanan, M., White, K.C., Laupland, K.B., Hackett, M.J., Ellison, G., and McNamara, R. (2026). Association Between Hyperchloremia and Neurological Outcomes in Traumatic Brain Injury: A Narrative Review. Healthcare, 14.","DOI":"10.3390\/healthcare14050696"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Ziaka, M., Hautz, W., and Exadaktylos, A. (2025). A Comprehensive Review of Fluid Resuscitation Strategies in Traumatic Brain Injury. J. Clin. Med., 14.","DOI":"10.3390\/jcm14176289"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Huet, O., Chapalain, X., Vermeersch, V., Moyer, J.D., Lasocki, S., Cohen, B., Dahyot-Fizelier, C., Chalard, K., Seguin, P., and Hourmant, Y. (2023). Impact of continuous hypertonic (NaCl 20%) saline solution on renal outcomes after traumatic brain injury (TBI): A post hoc analysis of the COBI trial. Crit. Care, 27.","DOI":"10.1186\/s13054-023-04311-1"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1711584","article-title":"Balanced Crystalloids versus Saline in Critically Ill Adults","volume":"378","author":"Semler","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Qureshi, A.I., Ma, X., Huang, W., Nunna, R.S., Gomez, F., Malhotra, K., Arora, N., Chandrasekaran, P.N., Siddiq, F., and Gomez, C.R. (2022). Early Hyperchloremia and Outcomes After Severe Traumatic Brain Injury: Analysis of Resuscitation Outcomes Consortium Hypertonic Saline Trial. Crit. Care Explor., 4.","DOI":"10.1097\/CCE.0000000000000797"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s12028-020-00928-0","article-title":"Hyperchloremia, not Concomitant Hypernatremia, Independently Predicts Early Mortality in Critically Ill Moderate-Severe Traumatic Brain Injury Patients","volume":"33","author":"Ditch","year":"2020","journal-title":"Neurocrit. Care"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1001\/jama.2021.5561","article-title":"Effect of Continuous Infusion of Hypertonic Saline vs Standard Care on 6-Month Neurological Outcomes in Patients with Traumatic Brain Injury: The COBI Randomized Clinical Trial","volume":"325","author":"Roquilly","year":"2021","journal-title":"JAMA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/MJT.0b013e3181cd816f","article-title":"The role of organic osmolytes in the response of cultured astrocytes to hyperosmolarity","volume":"18","author":"Hijab","year":"2011","journal-title":"Am. J. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.13004\/kjnt.2023.19.e25","article-title":"Optimizing Mannitol Use in Managing Increased Intracranial Pressure: A Comprehensive Review of Recent Research and Clinical Experiences","volume":"19","author":"Kim","year":"2023","journal-title":"Korean J. Neurotrauma"},{"key":"ref_25","first-page":"63","article-title":"Passage of mannitol into the brain around gliomas: A potential cause of rebound phenomenon. A study on 21 patients","volume":"50","author":"Palma","year":"2006","journal-title":"J. Neurosurg. Sci."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Bernini, A., Miroz, J.P., Abed-Maillard, S., Favre, E., Iaquaniello, C., Ben-Hamouda, N., and Oddo, M. (2022). Hypertonic lactate for the treatment of intracranial hypertension in patients with acute brain injury. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-07129-z"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12028-011-9512-0","article-title":"Randomized controlled trial comparing the effect of 8.4% sodium bicarbonate and 5% sodium chloride on raised intracranial pressure after traumatic brain injury","volume":"15","author":"Bourdeaux","year":"2011","journal-title":"Neurocrit. Care"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Sadan, O., Singbartl, K., Kraft, J., Plancher, J.M., Greven, A.C.M., Kandiah, P., Pimentel, C., Hall, C.L., Papangelou, A., and Asbury, W.H. (2020). Low-chloride- versus high-chloride-containing hypertonic solution for the treatment of subarachnoid hemorrhage-related complications: The ACETatE (A low ChloriE hyperTonic solution for brain Edema) randomized trial. J. Intensive Care, 8.","DOI":"10.1186\/s40560-020-00449-0"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Bishop, M.S., Lane, D.J.R., Ayton, S., May, C.N., Plummer, M.P., and Lankadeva, Y.R. (2026). Sodium ascorbate versus ascorbic acid in sepsis: A narrative review of emerging cardiovascular and neurological benefits. Crit. Care, 30.","DOI":"10.1186\/s13054-025-05831-8"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1089\/neu.2014.3483","article-title":"Lactate: Brain fuel in human traumatic brain injury: A comparison with normal healthy control subjects","volume":"32","author":"Glenn","year":"2015","journal-title":"J. Neurotrauma"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.cmet.2018.03.008","article-title":"The Science and Translation of Lactate Shuttle Theory","volume":"27","author":"Brooks","year":"2018","journal-title":"Cell Metab."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00134-008-1283-5","article-title":"Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients","volume":"35","author":"Ichai","year":"2009","journal-title":"Intensive Care Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00134-013-2978-9","article-title":"Half-molar sodium lactate infusion to prevent intracranial hypertensive episodes in severe traumatic brain injured patients: A randomized controlled trial","volume":"39","author":"Ichai","year":"2013","journal-title":"Intensive Care Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12028-010-9368-8","article-title":"Sodium bicarbonate lowers intracranial pressure after traumatic brain injury","volume":"13","author":"Bourdeaux","year":"2010","journal-title":"Neurocrit. Care"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1089\/neu.2020.7443","article-title":"Neuroprotective Properties of Vitamin C: A Scoping Review of Pre-Clinical and Clinical Studies","volume":"38","author":"Kangisser","year":"2021","journal-title":"J. Neurotrauma"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/01.STR.32.4.898","article-title":"Plasma vitamin C levels are decreased and correlated with brain damage in patients with intracranial hemorrhage or head trauma","volume":"32","author":"Polidori","year":"2001","journal-title":"Stroke"},{"key":"ref_37","first-page":"175","article-title":"Cerebrospinal fluid and plasma ascorbate concentrations following subarachnoid haemorrhage","volume":"25","author":"Turner","year":"2023","journal-title":"Crit. Care Resusc."},{"key":"ref_38","first-page":"40","article-title":"Brain oedema and intracranial hypertension treatment by GLIAS","volume":"55","author":"Oppido","year":"1992","journal-title":"Acta Neurochir. Suppl."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00003246-199803000-00011","article-title":"Use of hypertonic (3%) saline\/acetate infusion in the treatment of cerebral edema: Effect on intracranial pressure and lateral displacement of the brain","volume":"26","author":"Qureshi","year":"1998","journal-title":"Crit. Care Med."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Holden, D.N., Yung, F.H., and Entezami, P. (2021). Hypertonic saline buffered with sodium acetate for intracranial pressure management. Clin. Neurol. Neurosurg., 201.","DOI":"10.1016\/j.clineuro.2020.106435"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/neu.2019.6399","article-title":"Early Osmotherapy in Severe Traumatic Brain Injury: An International Multicenter Study","volume":"37","author":"Anstey","year":"2020","journal-title":"J. Neurotrauma"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"\u00c5kerlund, C.A., Donnelly, J., Zeiler, F.A., Helbok, R., Holst, A., Cabeleira, M., G\u00fciza, F., Meyfroidt, G., Czosnyka, M., and Smielewski, P. (2020). Impact of duration and magnitude of raised intracranial pressure on outcome after severe traumatic brain injury: A CENTER-TBI high-resolution group study. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0243427"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/17\/6860\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:38:49Z","timestamp":1788543529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/17\/6860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":42,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["jcm15176860"],"URL":"https:\/\/doi.org\/10.3390\/jcm15176860","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]}}}